BRCA1 and breast cancer: The elimination of aggregates after glycerol addition, however, provides proof of concept and supports the pursuit of small molecules that are well-tolerated in vivo and stabilize CASK protein containing a misfolding mutation, as has been proposed for other proteins with known missense mutations such as the breast cancer gene BRCA1 [88].